Last reviewed · How we verify

NCT03061084

Prospective Cohort of Transitional Urology Patients

Status unknown Last updated 6 February 2023
What this trial tests

trial in Spina Bifida in 200 participants. Status unknown.

Timeline
27 August 2015
Primary endpoint
31 December 2024
31 December 2024

Quick facts

Lead sponsorThe Methodist Hospital Research Institute
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment200
Start date27 August 2015
Primary completion31 December 2024
Estimated completion31 December 2024
Sites1 location across United States

Conditions studied

Sponsor

The Methodist Hospital Research Institute

Who can join

18 and older, any sex, with Spina Bifida or Myelomeningocele. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A transitional Urology database was created in parallel with National Spina Bifida registry to follow patients with complex congenital urogenital anomalies and be able to prospectively evaluate them. The investigators obtained the standardized questionnaires to collect long-term data regarding patients' genitourinary status including urine and fecal continence, sexuality, fertility, and pelvic health.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Spina Bifida

Currently open trials in the same condition.

Other The Methodist Hospital Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03061084.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing